CIK 0001755237
- Non-accelerated filer
- Smaller reporting company
Korsana Biosciences, Inc.
Sign in to watch- Ticker
- KRSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 831895370
- Phone
- +1 781-516-2325
- Business address
- 203 CRESCENT STREET, BLDGS. #3/3A/4, SUITE 503, WALTHAM, MA, 02453
- Former names
- Cyclerion Therapeutics, Inc.
- 4 Open-market buy 10% owner bought 961,538 shares at $3.12 ($2,999,999)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 302,000 shares at $2.43 ($733,860)
- 4 Open-market buy Chief Executive Officer bought 698,001 shares at an average $2.43 ($1,693,943)
- 4 Open-market sale Chief Financial Officer sold 1,824 shares at $4.00 ($7,296)
- 4 Open-market sale Chief Medical Officer sold 2,637 shares at $3.99 ($10,522)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President and CSO sold 20,107 shares at $3.01 ($60,522)
- 4 Open-market buy Chief Innovation Officer bought 125,000 shares at $2.53 ($316,250)
- 4 Open-market sale Chief Financial Officer sold 3,827 shares at $2.52 ($9,644)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 7 · 134 filings